Aspiriant LLC’s NextNav NN Stock Holding History

Aspiriant LLC’s Portfolio NN Stock Details NN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-33,412	Closed	-$596K	–	447
2026 Q2	$596K	Sell	33,412 -10,794	-24%	-$209K	0.01%	220
2026 Q1	$708K	Buy	+44,206	New	+$715K	0.02%	188

Other funds holding NN

MILFAM LLC Stuart, Florida $145M AUM

Richard P. Slaughter Associates Austin, Texas $506M AUM 14.83% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Kelly Financial Group Wethersfield, Connecticut $435M AUM 10.81% 1-Year Est. Return

Perigon Wealth Management San Francisco, California $6.5B AUM 20.72% 1-Year Est. Return

T3 Companies New York $103M AUM 54.73% 1-Year Est. Return

Obermeyer Wealth Partners Aspen, Colorado $2.51B AUM 18.87% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return

Steel Grove Capital Advisors Memphis, Tennessee $1.12B AUM 20.37% 1-Year Est. Return

Aspiriant LLC's NN Position: Q3 2026 in Review

Aspiriant LLC sold out of NextNav (NN) in Q3 2026, closing a stake of 33,412 shares — an estimated $596K sold.

Aspiriant LLC first reported a position in NN in Q1 2026 and held it in 2 quarters. The position peaked at $708K in Q1 2026. 36 funds tracked by Wall St. Rank hold NN as of Q3 2026.

Aspiriant LLC reported no remaining NextNav position as of Q3 2026 after selling out during the quarter.
Aspiriant LLC sold 33,412 NextNav shares in Q3 2026, an estimated $596K.
Aspiriant LLC first reported a position in NextNav in Q1 2026 and held it in 2 quarters.
Aspiriant LLC's NextNav position peaked at $708K in Q1 2026.
36 funds tracked by Wall St. Rank held NextNav as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.